July 19th 2021
For those in the community setting, several barriers to clinical research prevent advanced care providers and their patients from taking part in experimental therapies.
June 6th 2020
Pharmacists can play a role in the drug reimbursement process for oncology products, which are among the most expensive of all pharmaceuticals.
March 17th 2020
In January, America’s Health Insurance Plans in collaboration with payers representing 60 million covered individuals launched the Fast Prior Authorization Technology Highway to improve the prior authorization process.
March 9th 2020
The paradigm for treating patients with HER2-positive breast cancer is changing throughout the spectrum of the disease as a result of recent clinical trial findings regarding novel and established treatment regimens, according to Sara A. Hurvitz, MD
January 28th 2020
Recent studies have demonstrated that somatic mutations of ATM denote greater response to radiation therapy and that gene patterns may help predict the timing of recurrence following radiation.
October 31st 2017
A new generation of more selective inhibitors of CDK4 and CDK6 has entered the clinic in combination therapies for patients with breast cancer. These agents also are being investigated in patients with KRAS-mutant malignancies.
September 22nd 2017
EZH2 have been frequently observed in cancer, and small molecule inhibitors have been developed against the enzymatic activity of EZH2, with evidence of clinical activity in early-phase trials.